Interaction studies of multiple binding sites on M4 muscarinic acetylcholine receptors

被引:25
|
作者
Lanzafame, Alfred A.
Sexton, Patrick M.
Christopoulos, Arthur
机构
[1] Monash Univ, Drug Discovery Biol Lab, Dept Pharmacol, Clayton, Vic 3800, Australia
[2] Univ Melbourne, Dept Pharmacol, Melbourne, Vic, Australia
关键词
D O I
10.1124/mol.106.024711
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This study investigated the reciprocal cross-interactions between two distinct allosteric sites on the M 4 muscarinic acetylcholine receptor ( mAChR) in the absence or presence of different orthosteric ligands. Initial studies revealed that two novel benzimidazole allosteric modulators, 17-beta-hydroxy-17-beta-ethynyl-delta(4)-androstano[3,2-b]pyrimido[1,2-a]benzimidazole(WIN 62,577) and 17-beta-hydroxy-17-beta-ethynyl-5-beta-androstano[3,2-b]pyrimido[1,2-a]benzimidazole(WIN 51,708), exhibited different degrees of positive, negative, or close-to-neutral cooperativity with the orthosteric site on M-1 or M-4 mAChRs, depending on the chemical nature of the orthosteric radioligand that was used [[H-3] N-methylscopolamine ([H-3] NMS) versus [H-3] quinuclidinylbenzilate ([H-3]QNB)]. The largest window for observing an effect (negative cooperativity) was noted for the combination of WIN 62,577 and [H-3] QNB at the M 4 mAChR. Experiments involving the combination of these two ligands with unlabeled agonists [acetylcholine, 4-(m-chlorophenylcarbamoyloxy)2- butynyltrimethylammonium (McN-A-343), or xanomeline] revealed low degrees of negative cooperativity between WIN 62,577 and each agonist, whereas stronger negative cooperativity was observed against atropine. It is interesting that when these experiments were repeated using the prototypical modulators heptane-1,7-bis-(dimethyl-3 beta-phthalimidopropyl)ammonium bromide (C-7/3-phth), alcuronium, or brucine ( which act at a separate allosteric site), WIN 62,577 exhibited negative cooperativity with each modulator when the orthosteric site was unoccupied, but this switched to neutral cooperativity when the receptor was occupied by [H-3] QNB. Dissociation kinetic experiments using [H-3] NMS and combination of C-7/3-phth with WIN 62,577 also provided evidence for neutral cooperativity between the two allosteric sites when the orthosteric site is occupied. Together, these results provide insight into the nature of the interaction between two distinct allosteric sites on the M-4 mAChR and how this interaction is perturbed upon occupancy of the orthosteric site.
引用
收藏
页码:736 / 746
页数:11
相关论文
共 50 条
  • [41] Acetylcholine Muscarinic M4 Receptors as a Therapeutic Target for Alcohol Use Disorder: Converging Evidence From Humans and Rodents
    Walker, Leigh C.
    Berizzi, Alice E.
    Chen, Nicola A.
    Rueda, Patricia
    Perreau, Victoria M.
    Huckstep, Katherine
    Srisontiyakul, Jirawoot
    Govitrapong, Piyarat
    Jia Xiaojian
    Lindsley, Craig W.
    Jones, Carrie K.
    Riddy, Darren M.
    Christopoulos, Arthur
    Langmead, Christopher J.
    Lawrence, Andrew J.
    BIOLOGICAL PSYCHIATRY, 2020, 88 (12) : 898 - 909
  • [42] Activation of M1 and M4 muscarinic acetylcholine receptors biases excitatory synaptic transmission in hippocampus CA1
    Thorn, Catherine
    Stark, Eda
    Volfson, Dmitri
    Edgerton, Jeremy
    JOURNAL OF NEUROCHEMISTRY, 2017, 142 : 221 - 221
  • [43] Xanomeline wash-resistantly bound to presynaptic M2 and M4 muscarinic receptors decreases the evoked release of acetylcholine
    Machova, E.
    Jakubik, J.
    El-Fakahany, E. E.
    Dolezal, V.
    JOURNAL OF NEUROCHEMISTRY, 2007, 101 : 52 - 53
  • [44] MUSCARINIC ACETYLCHOLINE RECEPTORS INTERACTIONS - COMPETITION BINDING STUDIES WITH AGONISTS AND ANTAGONISTS
    KLOOG, Y
    SOKOLOVSKY, M
    BRAIN RESEARCH, 1977, 134 (01) : 167 - 172
  • [45] Discovery of dihydroquinazolinone derivatives as potent, selective, and CNS-penetrant M1 and M4 muscarinic acetylcholine receptors agonists
    Uruno, Yoshiharu
    Konishi, Yasuko
    Suwa, Atsushi
    Takai, Kentaro
    Tojo, Kengo
    Nakako, Tomokazu
    Sakai, Mutsuko
    Enomoto, Takeshi
    Matsuda, Harumi
    Kitamura, Atsushi
    Sumiyoshi, Takaaki
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (22) : 5357 - 5361
  • [46] DIFFERENTIAL REGULATION OF CAMP-MEDIATED GENE-TRANSCRIPTION BY M1 AND M4 MUSCARINIC ACETYLCHOLINE-RECEPTORS - PREFERENTIAL COUPLING OF M4 RECEPTORS TO G(I)ALPHA-2
    MIGEON, JC
    NATHANSON, NM
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (13) : 9767 - 9773
  • [47] Multiple binding sites in the nicotinic acetylcholine receptors: An opportunity for polypharmacolgy
    Iturriaga-Vasquez, Patricio
    Alzate-Morales, Jans
    Bermudez, Isabel
    Varas, Rodrigo
    Reyes-Parada, Miguel
    PHARMACOLOGICAL RESEARCH, 2015, 101 : 9 - 17
  • [48] BIOCHEMICAL STUDIES ON MUSCARINIC ACETYLCHOLINE RECEPTORS
    BIRDSALL, NJM
    HULME, EC
    JOURNAL OF NEUROCHEMISTRY, 1976, 27 (01) : 7 - 16
  • [49] DEVELOPMENT OF ANTISERA SELECTIVE FOR M4 AND M5 MUSCARINIC CHOLINERGIC RECEPTORS - DISTRIBUTION OF M4 AND M5 RECEPTORS IN RAT-BRAIN
    YASUDA, RP
    CIESLA, W
    FLORES, LR
    WALL, SJ
    LI, M
    SATKUS, SA
    WEISSTEIN, JS
    SPAGNOLA, BV
    WOLFE, BB
    MOLECULAR PHARMACOLOGY, 1993, 43 (02) : 149 - 157
  • [50] Interaction of edrophonium with muscarinic acetylcholine M2 and M3 receptors
    Tanito, Y
    Miwa, T
    Endou, M
    Hirose, Y
    Gamoh, M
    Nakaya, H
    Okumura, F
    ANESTHESIOLOGY, 2001, 94 (05) : 804 - 814